Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for antipsychotic-associated diabetes in metformin-treated adults with schizophrenia
NL-OMON24018Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- May 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Single-arm trial of liraglutide in drug-induced diabetes (DID) and obesity, sponsored by University Medical Center Utrecht. Primary endpoint: Change in HbA1c. Planned start May 2014; status: not yet recruiting.
02
Drugs
03
Conditions
drug-induced diabetes (DID)obesity
Beyond the preview
Go deeper on NL-OMON24018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24018.